Overview

Amiloride for Resistant Hypertension

Status:
Completed

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

To evaluate the antihypertensive effect of amiloride added to triple antihypertensive therapy in patients with resistant hypertension (RH) and type 2 diabetes mellitus (T2DM)

Phase:

Phase 4

Details

Lead Sponsor:

Ib Abildgaard Jacobsen

Treatments:

Amiloride